Regulating the Psychedelic Renaissance: FDA’s Critical Role in the Push for Scheduling Reform to Expand Research into Psychedelic Medicines
Document Type
Response or Comment
Publication Date
Summer 2024
Journal
American University Administrative Law Review
Volume
76
Issue
3
Abstract
Though Indigenous communities have used psychedelics in a medicinal capacity for centuries, their use in the United States has remained largely illegal since the 1970s as a result of the War on Drugs. In recent years, however, the broader sociocultural and governmental attitudes toward psychedelics have started to shift, leading to a greater push for legislative and regulatory reform—a phenomenon described as the psychedelic renaissance.
Recommended Citation
Sinha, Saumya, "Regulating the Psychedelic Renaissance: FDA’s Critical Role in the Push for Scheduling Reform to Expand Research into Psychedelic Medicines" (2024). Celebrating WCL Student Authors. 63.
https://digitalcommons.wcl.american.edu/stusch_lawrev/63